weight-loss drugs

Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say

by
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say

Novo Nordisk‘s and Eli Lilly‘s blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity and its complications, a major European medical association advised on Thursday. Semaglutide, the active ingredient in Novo’s Wegovy and Ozempic, and tirzepatide, sold as Zepbound and Mounjaro by Lilly, are so effective that they should be … Read more

Weight-loss drugs didn’t curb health costs within two years, data show

by
Weight-loss drugs didn’t curb health costs within two years, data show

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters. The full-year cost of care for U.S. patients with obesity two years after starting on Novo Nordisk’s Wegovy or similar GLP-1 drugs was $18,507, on average. That represents a 46% jump over … Read more